Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 11Unknown 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 30Carcinoma, Non-Small-Cell Lung 14Lung Neoplasms 9Neoplasm Metastasis 3Neoplasms 2Hodgkin Disease 2Adenocarcinoma of Lung 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Thoracic Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Recurrence 1Pancreatic Neoplasms 1Mesothelioma 1Malignant Solid Tumour 1Lymphoma, T-Cell, Peripheral 1Lymphoma 1Lung Diseases 1Breast Neoplasms, Male 1Advanced Non-Small Cell Lung Cancer 1Adenocarcinoma, Bronchiolo-Alveolar 1

Interventions

Rituximab 66Cyclophosphamide 52fludarabine phosphate 26fludarabine 22Filgrastim 21Vincristine 19Methotrexate 19Melphalan 19Doxorubicin 18Radiotherapy 17Etoposide 17Prednisone 16Tacrolimus 15Whole-Body Irradiation 14Mycophenolic Acid 14Cytarabine 14Peripheral Blood Stem Cell Transplantation 13Gemcitabine 13Cyclosporine 13Antilymphocyte Serum 13Lenalidomide 12Busulfan 11Bortezomib 11Granulocyte Colony-Stimulating Factor 9Alemtuzumab 9sargramostim 8Dexamethasone 8Cord Blood Stem Cell Transplantation 8pembrolizumab 7ibritumomab tiuxetan 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Lymphoma × Vinorelbine × Clear all
NCT00920153 2016-09-16

Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma

French Innovative Leukemia Organisation

Phase 3 Terminated
442 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡